Current advances in early detection, residual disease monitoring and treatment response in lung cancer: Liquid biopsy
Journal Title: Current Thoracic Surgery - Year 2018, Vol 3, Issue 2
Abstract
Lung cancer exhibits the highest mortality rate of all malignant tumors, and only a minority of non-small cell lung cancer (NSCLC) patients are diagnosed with localized, early stage tumors. Unfortunately, NSCLC is usually detected at advanced and inoperable stages. Tumor biomarkers can detect early stage lung cancer independently or in combination with low-dose computed tomography-based screening techniques. A liquid biopsy is a noninvasive modality for the pathological and molecular characterization of cancer, and it can be isolated from bodily fluids. There are a variety of biological elements that can be isolated from the peripheral blood, such as exosomes, circulating cell-free (tumor) DNA, circulating tumor cells, and microRNA. A liquid biopsy can be used to detect somatic mutations before treatment and dynamically during treatment, and to monitor the treatment response. It can also be used for minimal residual disease quantification, and to determine the emergence of therapy resistance. Despite the numerous research studies showing successful results, clinically available lung cancer biomarkers do not have sufficiently high specificity and sensitivity for widespread use. Therefore, universal experimental and therapeutic research regarding advanced molecular diagnostics has become necessary.
Authors and Affiliations
Ebru Sayılır Güven, Selim Şakir Erkmen Gülhan
Keywords
Related Articles
- EP ID EP517366
- DOI 10.26663/cts.2018.00019
- Views 51
- Downloads 0
Inflammatory myofibroblastic tumor: a case of a rare tumor of lung
Inflammatory myofibroblastic tumor (IMT) is a rare thoracic lesion, the diagnosis of which should be supported by histological and immunochemical examinations. Although this is known as a benign tumor, it should be compl...
Thoracic splenosis: a very rare cause of chest pain
Intrathoracic splenosis presents a rare thoracic lesion occurring after splenectomy or abdominal trauma as a consequence of heterotopic autotransplantation and implantation of splenic tissue. We present a 38- yearold man...
Analysis of risk factors in surgical treatment of lung cancer patients over 70 years of age: how effective are the cardiac risk score and age?
Background: In this study, the age and cardiac risk factors on mortality, and complications after surgical treatment in lung cancer patients were investigated. Materials and Methods: Between January 2014 and November 201...
Catamenial pneumothorax: a case report of recurrent spontaneous pneumothorax
Catamenial pneumothorax (CP) is a type of recurrent pneumothorax that occurs during menstrual periods in women. CP is a special type of pneumothorax related with the menstrual period and the treatment consists of both me...
Intradiaphragmatic bronchogenic cyst: a very rare diaphragmatic mass
Bronchogenic cysts are generally asymptomatic and are detected incidentally by radiographic imaging as a smooth homogeneous mediastinal/pulmonary lesion. Isolated intradiaphragmatic bronchogenic cysts are extremely rare....